Secondary hyperparathyroidism due to chronic kidney disease and access to clinical treatment and parathyroidectomy in Brazil: a nationwide survey
Authors:
- Lauter Eston PelepenkoLPLauter Eston Pelepenko
- Marcelo Giacomini LouçaMLMarcelo Giacomini Louça
- Tarcísio FaustoTFTarcísio Fausto
- Sergio Gardano Elias BucharlesSBSergio Gardano Elias Bucharles
- Melani Ribeiro CustódioMCMelani Ribeiro Custódio
- Leandro Lucca JuniorLJLeandro Lucca Junior
- Fellype de Carvalho BarretoFBFellype de Carvalho Barreto
- Aluízio Barbosa CarvalhoACAluízio Barbosa Carvalho
- Vanda JorgettiVJVanda Jorgetti
- José Andrade Moura NetoJNJosé Andrade Moura Neto
- Rodrigo Bueno de OliveiraRORodrigo Bueno de Oliveira
Open Access
- 1 April 2025
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 47 (2) , e20240158
Abstract
Introduction: Chronic kidney disease (CKD) may lead to secondary hyperparathyroidism (SHP) and its treatment is based on the control of hyperphosphatemia, hypocalcemia, and serum parathormone hormone levels (PTH) levels. Despite the advances in SHP treatment, therapeutic failure is frequent and CKD patients on dialysis require parathyroidectomy (PTx).Keywords
This publication has 37 references indexed in Scilit:
- Parathyroidectomy: better late than neverKidney International, 2015
- Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative StudyPLOS ONE, 2013
- Secondary hyperparathyroidism status in Brazil: Brazilian census of parathyroidectomy.2011
- Pharmacotherapy of chronic kidney disease and mineral bone disorderExpert Opinion on Pharmacotherapy, 2011
- Secondary HyperparathyroidismClinical Journal of the American Society of Nephrology, 2011
- Current status of parathyroidectomy for secondary hyperparathyroidism in JapanClinical Kidney Journal, 2008
- Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2005
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidismNephrology Dialysis Transplantation, 2004
- Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study.2001